[[F-18]-fluorodeoxyglucose (FDG) positron emission tomography (PET) as a diagnostic for hip endoprosthesis loosening]

Z Orthop Ihre Grenzgeb. 2003 Sep-Oct;141(5):540-6. doi: 10.1055/s-2003-42848.
[Article in German]

Abstract

Aim: The purpose of this study was to examine the FDG-PET in respect of its diagnostic valency with regard to septic/aseptic loosening of lower limb prostheses.

Method: 28 patients with 41 lower limb prostheses were examined by means of FDG-PET to evaluate septic/aseptic loosening of their hip prostheses. Therefore, a differentiated FDG-PET result interpretation subdivided into five categories was developed. The final diagnosis was based on operative findings with following culture and histological outcome.

Results: The worked-out categories showed a high agreement to the intraoperative macroscopic and histological results (n = 23 correctly positive, n = 1 false positive, n = 1 correctly negative and n = 3 false negative).

Conclusion: With a subtly differentiated interpretation (categories I - V) of the qualitative glucose metabolism safe statements can be made regarding septic/aseptic endoprostheses loosening. This was impressively confirmed by the agreement of the FDG results with the histological results.

Publication types

  • Clinical Trial
  • Validation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Equipment Failure Analysis / methods*
  • Female
  • Fluorodeoxyglucose F18*
  • Hip Joint / diagnostic imaging*
  • Hip Joint / pathology
  • Hip Joint / surgery*
  • Hip Prosthesis / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Failure*
  • Prosthesis-Related Infections / diagnostic imaging*
  • Prosthesis-Related Infections / etiology*
  • Prosthesis-Related Infections / pathology
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Statistics as Topic
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18